Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study

Published:2021-05-27 Issue:6 Volume:41 Page:515-525
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Belviso Nicholas¹,Aronow Herbert D.²³,Wyss Richard⁴,Barbour Marilyn¹,Zhang Yichi⁵,Wen Xuerong¹^ORCID,Kogut Stephen¹

Affiliation:

1. College of Pharmacy University of Rhode Island Kingston RI USA

2. Lifespan Cardiovascular Institute Providence RI USA

3. Warren Alpert Medical Scholl of Brown University Providence RI USA

4. Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women's Hospital Harvard Medical School Boston MA USA

5. Department of Computer Science and Statistics University of Rhode Island Kingston RI USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2530

Reference29 articles.

1. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

2. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

3. Dual Antiplatelet Therapy in Percutaneous Coronary Intervention

4. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

5. Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis;The American Journal of Cardiology;2023-11

2. Dual Antiplatelet Therapy: A Concise Review for Clinicians;Life;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3